Pharma-Bio Serv (PBSV) EPS (Weighted Average and Diluted) (2010 - 2026)
Pharma-Bio Serv (PBSV) reported EPS (Weighted Average and Diluted) of $0.01 for Q2 2026, up 150.0% year-over-year from $0.0 in Q2 2025, and up 900.0% on a QoQ basis from $0.0 in Q1 2026.
Pharma-Bio Serv (PBSV) EPS (Weighted Average and Diluted) (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's EPS (Weighted Average and Diluted) history runs 17 years deep, the most recent figure standing at $0.01 for Q2 2026.
- EPS (Weighted Average and Diluted) for Q2 2026 came in at $0.01, up 150.0% year-over-year; the trailing twelve-month figure through Apr 2026 was $0.01 (up 123.53% YoY), and the FY2025 annual result was -$0.0, up 88.24% from the prior year.
- EPS (Weighted Average and Diluted) came in at $0.01 for Q2 2026 at Pharma-Bio Serv, up from $0.0 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.02 in Q3 2023 to a low of -$0.07 in Q4 2024.
- A 5-year average of $0.0 and a median of $0.01 in 2025 frame the typical range for EPS (Weighted Average and Diluted).
- Across the five-year window, EPS (Weighted Average and Diluted) plunged 3265.68% in 2024 and soared 168.99% in 2026, its largest moves.
- Over 5 years, EPS (Weighted Average and Diluted) stood at $0.01 in 2022, then sank by 127.23% to -$0.0 in 2023, then plunged by 3265.68% to -$0.07 in 2024, then jumped by 88.41% to -$0.01 in 2025, then surged by 225.0% to $0.01 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at $0.01 (Q2 2026), $0.0 (Q1 2026), and -$0.01 (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.57 |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 0.67 |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 0.82 |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 0.41 |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -0.10 |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 0.10 |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 0.22 |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 0.02 |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 0.25 |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 0.01 |
| Jan 31, 2026 | 0.00 |
| Oct 31, 2025 | -0.01 |
| Jul 31, 2025 | 0.01 |
| Apr 30, 2025 | 0.00 |
| Jan 31, 2025 | 0.00 |
| Oct 31, 2024 | -0.07 |
| Jul 31, 2024 | 0.01 |
| Apr 30, 2024 | -0.01 |
| Jan 31, 2024 | -0.01 |
| Oct 31, 2023 | 0.00 |
| Jul 31, 2023 | 0.02 |
| Apr 30, 2023 | 0.02 |
| Jan 31, 2023 | 0.02 |
| Oct 31, 2022 | 0.01 |
| Jul 31, 2022 | 0.01 |
| Apr 30, 2022 | 0.01 |
| Jan 31, 2022 | 0.01 |
| Oct 31, 2021 | -0.21 |
| Jul 31, 2021 | 0.10 |